References
Key articles
Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. J Allergy Clin Immunol. 2020 Oct;146(4):721-67.Full text Abstract
Scadding GK, Kariyawasam HH, Scadding G, et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (revised edition 2017). Clin Exp Allergy. 2017 July;47(7):856-89.Full text Abstract
Wise SK, Lin SY, Toskala E, et al. International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol. 2018 Feb;8(2):108-352.Full text Abstract
Bousquet J, Schünemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020 Jan;145(1):70-80.e3.Full text Abstract
Reference articles
1. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008. Allergy. 2008 Apr;63 Suppl 86:8-160.Full text Abstract
2. Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines - 2016 revision. J Allergy Clin Immunol. 2017 Oct;140(4):950-8.Full text Abstract
3. Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. J Allergy Clin Immunol. 2020 Oct;146(4):721-67.Full text Abstract
4. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008 Aug;122(2 Suppl):S1-84.Full text Abstract
5. World Health Organization. International classification of diseases, 10th revision. 2019 [internet publication].Full text
6. European Academy of Allergy and Clinical Immunology. Global atlas of allergic rhinitis and chronic rhinosinusitis. Zurich, Switzerland: EAACI; 2015.Full text
7. Asher MI, Montefort S, Bjorksten B, et al. ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006 Aug 26;368(9537):733-43. Abstract
8. Meltzer EO, Blaiss MS, Naclerio RM, et al. Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys. Allergy Asthma Proc. 2012 Sep-Oct;33(suppl 1):S113-41. Abstract
9. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004 Nov;24(5):758-64.Full text Abstract
10. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001 Jul;108(1 Suppl):S2-8. Abstract
11. Pawankar R, Canonica GW, Colgate ST, et al. World Allergy Organization (WAO) white book on allergy: update 2013. Milwaukee, WI: World Allergy Organization; 2013.Full text
12. Mallol J, Crane J, von Mutius E, et al; ISAAC Phase Three Study Group. The International Study of Asthma and Allergies in Childhood (ISAAC) phase three: a global synthesis. Allergol Immunopathol (Madr). 2013 Mar-Apr;41(2):73-85. Abstract
13. Pinart M, Keller T, Reich A, et al. Sex-related allergic rhinitis prevalence switch from childhood to adulthood: a systematic review and meta-analysis. Int Arch Allergy Immunol. 2017;172(4):224-35. Abstract
14. Cao Y, Wu S, Zhang L, et al. Association of allergic rhinitis with obstructive sleep apnea: a meta-analysis. Medicine (Baltimore). 2018 Dec;97(51):e13783.Full text Abstract
15. Dávila I, Mullol J, Ferrer M, et al. Genetic aspects of allergic rhinitis. J Investig Allergol Clin Immunol. 2009;19 Suppl 1:25-31.Full text Abstract
16. Evans R. Epidemiology and natural history of asthma, allergic rhinitis, and atopic dermatitis (eczema). In: Middleton E, Reed C, Ellis E, eds. Allergy: principles and practice. 4th ed. St Louis, MO: Mosby; 1993:1109-36.
17. Waage J, Standl M, Curtin JA, et al. Genome-wide association and HLA fine-mapping studies identify risk loci and genetic pathways underlying allergic rhinitis. Nat Genet. 2018 Aug;50(8):1072-80.Full text Abstract
18. Chen HI, Lin YT, Jung CR, et al. Interaction between catalase gene promoter polymorphisms and indoor environmental exposure in childhood allergic rhinitis. Epidemiology. 2017 Oct;28 Suppl 1:S126-32. Abstract
19. Li CH, Sayeau K, Ellis AK. Air pollution and allergic rhinitis: role in symptom exacerbation and strategies for management. J Asthma Allergy. 2020 Aug 26;13:285-92.Full text Abstract
20. Zhang Y, Tan M, Qian X, et al. Interaction between early-life pet exposure and methylation pattern of ADAM33 on allergic rhinitis among children aged 3-6 years in China. Allergy Asthma Clin Immunol. 2021 May 1;17(1):44.Full text Abstract
21. Dunlop J, Matsui E, Sharma HP. Allergic rhinitis: environmental determinants. Immunol Allergy Clin North Am. 2016 May;36(2):367-77. Abstract
22. Jaakkola MS, Quansah R, Hugg TT, et al. Association of indoor dampness and molds with rhinitis risk: a systematic review and meta-analysis. J Allergy Clin Immunol. 2013 Nov;132(5):1099-1110.e18.Full text Abstract
23. Christensen SH, Timm S, Janson C, et al. A clear urban-rural gradient of allergic rhinitis in a population-based study in Northern Europe. Eur Clin Respir J. 2016 Nov 26;3:33463.Full text Abstract
24. Burbank AJ, Hernandez ML, Jefferson A, et al. Environmental justice and allergic disease: a Work Group report of the AAAAI Environmental Exposure and Respiratory Health Committee and the Diversity, Equity and Inclusion Committee. J Allergy Clin Immunol. 2023 Mar;151(3):656-70.Full text Abstract
25. Shreiner A, Huffnagle GB, Noverr MC. The "Microflora Hypothesis" of allergic disease. Adv Exp Med Biol. 2008;635:113-34. Abstract
26. Martinez FD, Holt PG. Role of microbial burden in aetiology of allergy and asthma. Lancet. 1999 Sep;354 (suppl 2):SII12-5.Full text Abstract
27. Björkstén B. Effects of intestinal microflora and the environment on the development of asthma and allergy. Springer Semin Immunopathol. 2004 Feb;25(3-4):257-70. Abstract
28. Fiocchi A, Pawankar R, Cuello-Garcia C, et al. World Allergy Organization-McMaster University guidelines for allergic disease prevention (GLAD-P): probiotics. World Allergy Organ J. 2015 Jan 27;8(1):4.Full text Abstract
29. Cuello-Garcia CA, Fiocchi A, Pawankar R, et al. World Allergy Organization-McMaster University guidelines for allergic disease prevention (GLAD-P): prebiotics. World Allergy Organ J. 2016 Mar 1;9:10.Full text Abstract
30. Wang DY. Risk factors of allergic rhinitis: genetic or environmental? Ther Clin Risk Manag. 2005 Jun;1(2):115-23.Full text Abstract
31. Barnes KC, Marsh DG. The genetics and complexity of allergy and asthma. Immunol Today. 1998 Jul;19(7):325-32. Abstract
32. Testa D, DI Bari M, Nunziata M, et al. Allergic rhinitis and asthma assessment of risk factors in pediatric patients: a systematic review. Int J Pediatr Otorhinolaryngol. 2020 Feb;129:109759. Abstract
33. Wang XD, Zheng M, Lou HF, et al. An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011. Allergy. 2016 Aug;71(8):1170-80.Full text Abstract
34. Hassoun Y, James C, Bernstein DI. The effects of air pollution on the development of atopic disease. Clin Rev Allergy Immunol. 2019 Dec;57(3):403-14.Full text Abstract
35. Saulyte J, Regueira C, Montes-Martínez A, et al. Active or passive exposure to tobacco smoking and allergic rhinitis, allergic dermatitis, and food allergy in adults and children: a systematic review and meta-analysis. PLoS Med. 2014 Mar;11(3):e1001611.Full text Abstract
36. Wallace DV. Pet dander and perennial allergic rhinitis: therapeutic options. Allergy Asthma Proc. 2009 Nov-Dec;30(6):573-83. Abstract
37. National Institute for Health and Care Excellence. Clinical knowledge summaries: allergic rhinitis. Aug 2021 [internet publication].Full text
38. Ojwang V, Nwaru BI, Takkinen HM, et al. Early exposure to cats, dogs and farm animals and the risk of childhood asthma and allergy. Pediatr Allergy Immunol. 2020 Apr;31(3):265-72. Abstract
39. Fall T, Lundholm C, Örtqvist AK, et al. Early exposure to dogs and farm animals and the risk of childhood asthma. JAMA Pediatr. 2015 Nov;169(11):e153219.Full text Abstract
40. Riedler J, Braun-Fahrlander C, Eder W, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet. 2001 Oct 6;358(9288):1129-33. Abstract
41. Stevenson MD, Sellins S, Grube E, et al. Aeroallergen sensitization in healthy children: racial and socioeconomic correlates. J Pediatr. 2007 Aug;151(2):187-91. Abstract
42. Szentpetery SE, Forno E, Canino G, et al. Asthma in Puerto Ricans: lessons from a high-risk population. J Allergy Clin Immunol. 2016 Dec;138(6):1556-8.Full text Abstract
43. Gillam SJ, Jarman B, White P, et al. Ethnic differences in consultation rates in urban general practice. BMJ. 1989 Oct 14;299(6705):953-7.Full text Abstract
44. American Academy of Allergy, Asthma & Immunology. Ten things physicians and patients should question. Choosing Wisely, an initiative of the ABIM Foundation. 2021 [internet publication].Full text
45. Greer FR, Sicherer SH, Burks AW, et al; American Academy of Pediatrics: Committee on Nutrition; Section on Allergy and Immunology. The effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, hydrolyzed formulas, and timing of introduction of allergenic complementary foods. Pediatrics. 2019 Apr;143(4):e20190281.Full text Abstract
46. Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD000133.Full text Abstract
47. Cuello-Garcia CA, Brożek JL, Fiocchi A, et al. Probiotics for the prevention of allergy: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol. 2015 Oct;136(4):952-61.Full text Abstract
48. Obbagy JE, English LK, Wong YP, et al. Complementary feeding and food allergy, atopic dermatitis/eczema, asthma, and allergic rhinitis: a systematic review. Am J Clin Nutr. 2019 Mar 1;109(suppl_7):890S-934S.Full text Abstract
49. Grabenhenrich LB, Keil T, Reich A, et al. Prediction and prevention of allergic rhinitis: a birth cohort study of 20 years. J Allergy Clin Immunol. 2015 Oct;136(4):932-40.e12.Full text Abstract
50. American Academy of Otolaryngology—Head and Neck Surgery Foundation. Ten things physicians and patients should question. Choosing Wisely, an initiative of the ABIM Foundation. 2021 [internet publication].Full text
51. Seidman MD, Gurgel RK, Lin SY; Guideline Otolaryngology Development Group. AAO-HNSF. Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg. 2015 Feb;152(1 Suppl):S1-43.Full text Abstract
52. Scadding GK, Kariyawasam HH, Scadding G, et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (revised edition 2017). Clin Exp Allergy. 2017 July;47(7):856-89.Full text Abstract
53. Wise SK, Lin SY, Toskala E, et al. International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol. 2018 Feb;8(2):108-352.Full text Abstract
54. Meltzer EO, Schatz M, Nathan R, et al. Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis. J Allergy Clin Immunol. 2013 Feb;131(2):379-86.Full text Abstract
55. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol. 1999 Aug;104(2 Pt 1):364-9. Abstract
56. Juniper EF, Riis B, Juniper BA. Development and validation of an electronic version of the Rhinoconjunctivitis Quality of Life Questionnaire. Allergy. 2007 Sep;62(9):1091-3. Abstract
57. Bousquet J, Heinzerling L, Bachert C, et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy. 2012 Jan;67(1):18-24. Abstract
58. Hamizan AW, Rimmer J, Alvarado R, et al. Positive allergen reaction in allergic and nonallergic rhinitis: a systematic review. Int Forum Allergy Rhinol. 2017 Sep;7(9):868-77. Abstract
59. Blanc S, Bourrier T, Albertini M, et al. Dennie-Morgan fold plus dark circles: suspect atopy at first sight. J Pediatr. 2015 Jun;166(6):1541. Abstract
60. Lindberg S, Malm L. Comparison of allergic rhinitis and vasomotor rhinitis patients on the basis of a computer questionnaire. Allergy. 1993 Nov;48(8):602-7. Abstract
61. Sur DKC, Plesa ML. Chronic nonallergic rhinitis. Am Fam Physician. 2018 Aug 1;98(3):171-6.Full text Abstract
62. Bernstein JA, Brandt D, Ratner P, et al. Assessment of a rhinitis questionnaire in a seasonal allergic rhinitis population. Ann Allergy Asthma Immunol. 2008 May;100(5):512-3. Abstract
63. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004 Dec;114(6 Suppl):155-212. Abstract
64. Gurgel RK, Baroody FM, Damask CC, et al. Clinical practice guideline: immunotherapy for inhalant allergy. Otolaryngol Head Neck Surg. 2024 Mar;170 Suppl 1:S1-42.Full text Abstract
65. Okubo K, Kurono Y, Ichimura K, et al. Japanese guidelines for allergic rhinitis 2020. Allergol Int. 2020 Jul;69(3):331-45.Full text Abstract
66. Australasian Society of Clinical Immunology and Allergy (ASCIA). Australasian guidelines for allergic rhinitis 2020. 2022 [internet publication].Full text
67. Bousquet J, Schünemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020 Jan;145(1):70-80.e3.Full text Abstract
68. NHS Specialist Pharmacy Service. Which oral antihistamines are safe to use whilst breastfeeding? Apr 2020 [internet publication].Full text
69. Kok TH, Taitz LS, Bennett MJ, et al. Drowsiness due to clemastine transmitted in breast milk. Lancet. 1982 Apr 17;1(8277):914-5. Abstract
70. US Food and Drug Administration. FDA drug safety communication: FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis. Mar 2020 [internet publication].Full text
71. Australasian Society of Clinical Immunology and Allergy. Allergen minimisation. Mar 2019 [internet publication].Full text
72. Sheikh A, Hurwitz B, Nurmatov U, et al. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev. 2010 Jul 7;(7):CD001563.Full text Abstract
73. Vredegoor DW, Willemse T, Chapman MD, et al. Can f 1 levels in hair and homes of different dog breeds: lack of evidence to describe any dog breed as hypoallergenic. J Allergy Clin Immunol. 2012 Oct;130(4):904-9.e7.Full text Abstract
74. Liem O, Kessen K, de Groot H. Hypoallergenic animals, fact or myth? [in Dutch]. Ned Tijdschr Geneeskd. 2019 Dec 31;164:D4298. Abstract
75. Nageotte C, Park M, Havstad S, et al. Duration of airborne Fel d 1 reduction after cat washing. J Allergy Clin Immunol. 2006 Aug;118(2):521-2. Abstract
76. Klucka CV, Ownby DR, Green J, et al. Cat shedding of Fel d I is not reduced by washings, Allerpet-C spray, or acepromazine. J Allergy Clin Immunol. 1995 Jun;95(6):1164-71. Abstract
77. Sulser C, Schulz G, Wagner P, et al. Can the use of HEPA cleaners in homes of asthmatic children and adolescents sensitized to cat and dog allergens decrease bronchial hyperresponsiveness and allergen contents in solid dust? Int Arch Allergy Immunol. 2009;148(1):23-30. Abstract
78. Wood RA, Johnson EF, Van Natta ML, et al. A placebo-controlled trial of a HEPA air cleaner in the treatment of cat allergy. Am J Respir Crit Care Med. 1998 Jul;158(1):115-20. Abstract
79. Huss K, Adkinson NF Jr, Eggleston PA, et al. House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program. J Allergy Clin Immunol. 2001 Jan;107(1):48-54. Abstract
80. Wood RA, Eggleston PA, Rand C, et al. Cockroach allergen abatement with extermination and sodium hypochlorite cleaning in inner-city homes. Ann Allergy Asthma Immunol. 2001 Jul;87(1):60-4. Abstract
81. Bousquet J, Devillier P, Arnavielhe S, et al. Treatment of allergic rhinitis using mobile technology with real-world data: the MASK observational pilot study. Allergy. 2018 Sep;73(9):1763-74.Full text Abstract
82. Xiao J, Wu WX, Ye YY, et al. A network meta-analysis of randomized controlled trials focusing on different allergic rhinitis medications. Am J Ther. 2016 Nov/Dec;23(6):e1568-78. Abstract
83. New Zealand Medicines and Medical Devices Safety Authority (Medsafe). Children and sedating antihistamines. Mar 2013 [internet publication].Full text
84. Blaiss MS. Evolving paradigm in the management of allergic rhinitis-associated ocular symptoms: role of intranasal corticosteroids. Curr Med Res Opin. 2008 Mar;24(3):821-36. Abstract
85. Naclerio R. Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis. Otolaryngol Head Neck Surg. 2008 Feb;138(2):129-39. Abstract
86. Dhami S, Nurmatov U, Arasi S, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Allergy. 2017 Nov;72(11):1597-631.Full text Abstract
87. Radulovic S, Calderon MA, Wilson D, et al. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD002893.Full text Abstract
88. Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007 Aug;62(8):943-8. Abstract
89. Durham SR, Emminger W, Kapp A, et al. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol. 2012 Mar;129(3):717-25.e5.Full text Abstract
90. Dretzke J, Meadows A, Novielli N, et al. Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison. J Allergy Clin Immunol. 2013 May;131(5):1361-6.Full text Abstract
91. Lin SY, Erekosima N, Kim JM, et al. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA. 2013 Mar 27;309(12):1278-88.Full text Abstract
92. Durham SR, Creticos PS, Nelson HS, et al. Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: pooled analyses. J Allergy Clin Immunol. 2016 Oct;138(4):1081-8.Full text Abstract
93. Di Bona D, Plaia A, Leto-Barone MS, et al. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison. J Allergy Clin Immunol. 2012 Nov;130(5):1097-107.e2. Abstract
94. Canonica GW, Cox L, Pawankar R, et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J. 2014 Mar 28;7(1):6.Full text Abstract
95. Calderon MA, Eichel A, Makatsori M, et al. Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials. Curr Opin Allergy Clin Immunol. 2012 Jun;12(3):249-56. Abstract
96. Demoly P, Emminger W, Rehm D, et al. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: results from a randomized double-blind, placebo-controlled phase III trial. J Allergy Clin Immunol. 2016 Feb;137(2):444-51.e8.Full text Abstract
97. Blaiss M, Maloney J, Nolte H, et al. Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents. J Allergy Clin Immunol. 2011 Jan;127(1):64-71, 71.e1-4. Abstract
98. Durham SR; GT-08 investigators. Sustained effects of grass pollen AIT. Allergy. 2011 Jul;66 (Suppl 95):50-2. Abstract
99. Nelson HS, Nolte H, Creticos P, et al. Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults. J Allergy Clin Immunol. 2011 Jan;127(1):72-80, 80.e1-2. Abstract
100. Creticos PS, Esch RE, Couroux P, et al. Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2014 Mar;133(3):751-8.Full text Abstract
101. Durham SR, Emminger W, Kapp A, et al. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol. 2010 Jan;125(1):131-8.e1-7. Abstract
102. Walker SM, Pajno GB, Lima MT, et al. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol. 2001 Jan;107(1):87-93. Abstract
103. Nacaroglu HT, Erdem SB, Sumer O, et al. Local and systemic reactions to subcutaneous allergen immunotherapy: ten years' experience in a pediatric clinic. Ann Allergy Asthma Immunol. 2016 Apr;116(4):349-53. Abstract
104. Gur Cetinkaya P, Kahveci M, Esenboğa S, et al. Systemic and large local reactions during subcutaneous grass pollen immunotherapy in children. Pediatr Allergy Immunol. 2020 Aug;31(6):643-50. Abstract
105. Li JT. Immunotherapy for allergic rhinitis. Immunol Allergy Clin North Am. 2000 May;20(2):383-400.Full text
106. Bernstein DI, Wanner M, Borish L, et al. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol. 2004 Jun;113(6):1129-36. Abstract
107. Greenhawt M, Oppenheimer J, Nelson M, et al. Sublingual immunotherapy: a focused allergen immunotherapy practice parameter update. Ann Allergy Asthma Immunol. 2017 Mar;118(3):276-82.e2.Full text Abstract
108. Roberts G, Pfaar O, Akdis CA, et al. EAACI Guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy. 2018 Apr;73(4):765-98.Full text Abstract
109. Linna O, Kokkonen J, Lukin M. A 10-year prognosis for childhood allergic rhinitis. Acta Paediatr. 1992 Feb;81(2):100-2. Abstract
110. Greisner WA III, Settipane RJ, Settipane GA. Natural history of hay fever: a 23-year follow-up of college students. Allergy Asthma Proc. 1998 Sep-Oct;19(5):271-5. Abstract
Use of this content is subject to our disclaimer